BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 27221674)

  • 21. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro study on expression of tumor stem cell biomarker and transdifferentiation towards endothelial cells of retinoblastoma cells under hypoxia condition].
    Zhang LN; Zhao GQ; Wang Q; Niu YJ; Xu Q; Yang WY
    Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):736-43. PubMed ID: 24246814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha.
    Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Kim CH; Yoo YD; Lee JC
    Oncol Rep; 2009 Mar; 21(3):801-7. PubMed ID: 19212642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma.
    Wang L; Lin N; Li Y
    Oncol Rep; 2019 Mar; 41(3):1678-1690. PubMed ID: 30664164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
    Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
    Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
    Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y
    Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
    Ao Q; Su W; Guo S; Cai L; Huang L
    Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.
    Shan JZ; Xuan YY; Zhang Q; Huang JJ
    J Zhejiang Univ Sci B; 2016 Sep; 17(9):672-82. PubMed ID: 27604859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.
    Wu D; Lu P; Mi X; Miao J
    Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia inducible factor 2α/insulin-like growth factor receptor signal loop supports the proliferation and Oct-4 maintenance of mouse germline stem cells.
    Huang YH; Lin MH; Wang PC; Wu YC; Chiang HL; Wang YL; Chang JH; Huang YK; Gu SY; Ho HN; Ling TY
    Mol Hum Reprod; 2014 Jun; 20(6):526-37. PubMed ID: 24598112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia pathway and hypoxia-mediated extensive extramedullary hematopoiesis are involved in ursolic acid's anti-metastatic effect in 4T1 tumor bearing mice.
    Gao JL; Shui YM; Jiang W; Huang EY; Shou QY; Ji X; He BC; Lv GY; He TC
    Oncotarget; 2016 Nov; 7(44):71802-71816. PubMed ID: 27708244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression.
    Zhang J; Xu J; Dong Y; Huang B
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29899167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
    Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.